BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28649742)

  • 1. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
    Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
    Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of genes encoding ATP-dependent chromatin remodellers identifies CHD7 as a potential target for colorectal cancer therapy.
    Zhang X; Zhou Y; Shi Z; Liu Z; Chen H; Wang X; Cheng Y; Xi L; Li X; Zhang C; Bao L; Xuan C
    Clin Transl Med; 2022 Jul; 12(7):e953. PubMed ID: 35789070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.
    Mills AA
    Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 28096241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
    Jiang Y; Liu L; Shan W; Yang ZQ
    Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.
    Yu H; Jiang Y; Liu L; Shan W; Chu X; Yang Z; Yang ZQ
    Oncotarget; 2017 Feb; 8(8):13099-13115. PubMed ID: 28055972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel N-terminal Region to Chromodomain in CHD7 is Required for the Efficient Remodeling Activity.
    Lee E; Kang C; Purhonen P; Hebert H; Bouazoune K; Hohng S; Song JJ
    J Mol Biol; 2021 Sep; 433(18):167114. PubMed ID: 34161779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
    Lu M; Ding N; Zhuang S; Li Y
    Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.
    Tahara T; Yamamoto E; Madireddi P; Suzuki H; Maruyama R; Chung W; Garriga J; Jelinek J; Yamano HO; Sugai T; Kondo Y; Toyota M; Issa JP; Estécio MR
    Gastroenterology; 2014 Feb; 146(2):530-38.e5. PubMed ID: 24211491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation update on the CHD7 gene involved in CHARGE syndrome.
    Janssen N; Bergman JE; Swertz MA; Tranebjaerg L; Lodahl M; Schoots J; Hofstra RM; van Ravenswaaij-Arts CM; Hoefsloot LH
    Hum Mutat; 2012 Aug; 33(8):1149-60. PubMed ID: 22461308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.
    Schnetz MP; Bartels CF; Shastri K; Balasubramanian D; Zentner GE; Balaji R; Zhang X; Song L; Wang Z; Laframboise T; Crawford GE; Scacheri PC
    Genome Res; 2009 Apr; 19(4):590-601. PubMed ID: 19251738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature.
    Machado RAC; Schneider H; DeOcesano-Pereira C; Lichtenstein F; Andrade F; Fujita A; Trombetta-Lima M; Weller M; Bowman-Colin C; Sogayar MC
    Sci Rep; 2019 Mar; 9(1):3952. PubMed ID: 30850678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHD7 cooperates with PBAF to control multipotent neural crest formation.
    Bajpai R; Chen DA; Rada-Iglesias A; Zhang J; Xiong Y; Helms J; Chang CP; Zhao Y; Swigut T; Wysocka J
    Nature; 2010 Feb; 463(7283):958-62. PubMed ID: 20130577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.
    Manning BJ; Yusufzai T
    J Biol Chem; 2017 Jul; 292(28):11927-11936. PubMed ID: 28533432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
    Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells.
    Sanosaka T; Okuno H; Mizota N; Andoh-Noda T; Sato M; Tomooka R; Banno S; Kohyama J; Okano H
    Sci Rep; 2022 Dec; 12(1):22648. PubMed ID: 36587182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.
    Colbert LE; Petrova AV; Fisher SB; Pantazides BG; Madden MZ; Hardy CW; Warren MD; Pan Y; Nagaraju GP; Liu EA; Saka B; Hall WA; Shelton JW; Gandhi K; Pauly R; Kowalski J; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Curran WJ; Landry JC; Maithel SK; Yu DS
    Cancer Res; 2014 May; 74(10):2677-87. PubMed ID: 24626090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.
    Shan W; Jiang Y; Yu H; Huang Q; Liu L; Guo X; Li L; Mi Q; Zhang K; Yang Z
    Am J Cancer Res; 2017; 7(5):1213-1226. PubMed ID: 28560068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of circ-SFMBT2 blocks the development of gastric cancer by targeting the miR-885-3p/CHD7 pathway.
    He Y; Zhang Z; Wang Z; Jiao Y; Kang Q; Li J
    Anticancer Drugs; 2022 Jan; 33(1):e247-e259. PubMed ID: 34387601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.
    Wu X; Zhu Z; Li W; Fu X; Su D; Fu L; Zhang Z; Luo A; Sun X; Fu L; Dong JT
    Breast Cancer Res; 2012 May; 14(3):R73. PubMed ID: 22569290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders.
    Bouazoune K; Kingston RE
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19238-43. PubMed ID: 23134727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.